Literature DB >> 29212700

The Alere BinaxNOW Pneumococcal Urinary Antigen Test: Diagnostic Sensitivity for Adult Pneumococcal Pneumonia and Relationship to Specific Serotypes.

Hisashi Shoji1, Arnau Domenech1, Antonella Francesca Simonetti2, Aida González1,3, Dolores García-Somoza1,3, Meritxell Cubero1,3, Sara Martí1,3, Masayuki Maeda4, Fe Tubau1,3, Josefina Liñares1,3, Maria Angeles Domínguez1,5, Jordi Carratalà2,5, Carmen Ardanuy6,3.   

Abstract

Little is known about the sensitivity of the BinaxNOW pneumococcal urinary antigen (PUA) test for adult pneumococcal pneumonia caused by different serotypes. In this study, we aimed to analyze the trends in the sensitivity of the PUA test over a 15-year period (2001 to 2015) and to analyze its sensitivity for pneumococcal pneumonia caused by different serotypes. In total, we analyzed 1,096 pneumococcal isolates from adults with pneumococcal pneumonia who had a PUA test performed at the onset of the episode. Three periods were analyzed: 2001 to 2005 (early use of the seven-valent pneumococcal conjugate vaccine [early PCV7]), 2006 to 2010 (late PCV7), and 2011 to 2015 (early PCV13). The sensitivity of the PUA test varied from 76.4% (95% confidence interval [CI], 70.5% to 82.4%) in the period from 2001 to 2005 to 77.9% in 2006 to 2010 (95% CI, 74.4% to 81.4%) and decreased to 60.5% (95% CI, 55.4% to 65.6%) in 2011 to 2015. This decrease was observed in 560 proven (83.2% in 2001 to 2005, 86.5% in 2006 to 2010, and 78.1%) and 536 probable (70.0% in 2001 to 2005, 68.7% in 2006 to 2010, and 41.5% in 2011 to 2015) episodes of pneumococcal pneumonia. Differences were observed in the sensitivity of the PUA test for diagnosing pneumonia caused by certain serotypes, being highest for the 9V (90.6%), 14 (86.8%), 18C (100%), and 20 (100%) serotypes and lowest for the 8 (55.2%), 9L/N (39.1%), 11A (48.8%), 23B (33.3%), and nontypeable (47.8%) serotypes. Comparing 2001 to 2005, 2006 to 2010, and 2011 to 2015, the prevalence of serotypes 9V (3.1%, 3.7%, and 1.7%, respectively) and 14 (7.2%, 5.1%, and 3.1%, respectively) decreased, while the prevalence of serotypes 23B (0%, 0.7%, and 1.4%, respectively), 9L/N (1.0%, 1.6%, and 3.4%, respectively), 11A (2.6%, 4.2%, and 3.7%, respectively), and 8 (1.5%, 1.5%, and 5.1%, respectively) increased. The PUA test sensitivity varied by pneumococcal pneumonia serotype, and these differences and the changes in serotype distribution were associated with an overall decrease in the sensitivity of the PUA test.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Streptococcus pneumoniae; community-acquired pneumonia; invasive pneumococcal disease; pneumococcal conjugate vaccine; pneumococcal urinary antigen test

Mesh:

Substances:

Year:  2018        PMID: 29212700      PMCID: PMC5786729          DOI: 10.1128/JCM.00787-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia.

Authors:  Beatriz Rosón; Nuria Fernández-Sabé; Jordi Carratalà; Ricard Verdaguer; Jordi Dorca; Frederic Manresa; Francesc Gudiol
Journal:  Clin Infect Dis       Date:  2003-12-18       Impact factor: 9.079

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

3.  Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.

Authors:  Diego Viasus; Antonella F Simonetti; Carolina Garcia-Vidal; Jordi Niubó; Jordi Dorca; Jordi Carratalà
Journal:  J Antimicrob Chemother       Date:  2016-10-20       Impact factor: 5.790

4.  Evaluation of a new lateral flow test for detection of Streptococcus pneumoniae and Legionella pneumophila urinary antigen.

Authors:  Charlotte S Jørgensen; Søren A Uldum; Jesper F Sørensen; Ian C Skovsted; Sanne Otte; Pernille L Elverdal
Journal:  J Microbiol Methods       Date:  2015-07-02       Impact factor: 2.363

5.  The rise and fall of pneumococcal serotypes carried in the PCV era.

Authors:  Vanessa T Devine; David W Cleary; Johanna M C Jefferies; Rebecca Anderson; Denise E Morris; Andrew C Tuck; Rebecca A Gladstone; Grace O'Doherty; Priyasharmila Kuruparan; Stephen D Bentley; Saul N Faust; Stuart C Clarke
Journal:  Vaccine       Date:  2017-02-01       Impact factor: 3.641

6.  The teichoic acid (C-polysaccharide) synthesized by Streptococcus pneumoniae serotype 5 has a specific structure.

Authors:  Sandrine Vialle; Patricia Sepulcri; Jean Dubayle; Philippe Talaga
Journal:  Carbohydr Res       Date:  2005-01-17       Impact factor: 2.104

7.  The pneumococcal common antigen C-polysaccharide occurs in different forms. Mono-substituted or di-substituted with phosphocholine.

Authors:  C Karlsson; P E Jansson; U B Skov Sørensen
Journal:  Eur J Biochem       Date:  1999-11

Review 8.  Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae.

Authors:  Alison Sinclair; Xuanqian Xie; Marty Teltscher; Nandini Dendukuri
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

9.  Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.

Authors:  Jordi Càmara; José María Marimón; Emilia Cercenado; Nieves Larrosa; María Dolores Quesada; Dionísia Fontanals; Meritxell Cubero; Emilio Pérez-Trallero; Asunción Fenoll; Josefina Liñares; Carmen Ardanuy
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 10.  Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.

Authors:  Maria A Said; Hope L Johnson; Bareng A S Nonyane; Maria Deloria-Knoll; Katherine L O'Brien; Felipe Andreo; Bojana Beovic; Silvia Blanco; Wim G Boersma; David R Boulware; Jay C Butler; Jordi Carratalà; Feng-Yee Chang; Patrick G P Charles; Alejandro A Diaz; Jose Domínguez; Naomi Ehara; Henrik Endeman; Vicenç Falcó; Miquel Falguera; Kiyoyasu Fukushima; Carolina Garcia-Vidal; Daniel Genne; Igor A Guchev; Felix Gutierrez; Susanne S Hernes; Andy I M Hoepelman; Ulla Hohenthal; Niclas Johansson; Vitezslav Kolek; Roman S Kozlov; Tsai-Ling Lauderdale; Ivana Mareković; Mar Masiá; Matta A Matta; Òscar Miró; David R Murdoch; Eric Nuermberger; Richard Paolini; Rafael Perelló; Dominic Snijders; Vanda Plečko; Roger Sordé; Kristoffer Strålin; Menno M van der Eerden; Angel Vila-Corcoles; James P Watt
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more
  9 in total

1.  Answer to February 2019 Photo Quiz.

Authors:  Cinzia Tavano; Renée Pasciuta; Silvia Carletti; Cristina M Ossi; Rossella Ieri; Paola Cichero; Nicola Clementi; Roberto Burioni; Massimo Clementi; Nicasio Mancini
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol.

Authors:  Gabriela Abelenda-Alonso; Alexander Rombauts; Carlota Gudiol; Yolanda Meije; Mercedes Clemente; Lucía Ortega; Carmen Ardanuy; Jordi Niubó; Ariadna Padullés; Sebastian Videla; Cristian Tebe; Jordi Carratalà
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

Review 3.  Urinary Antigen Testing for Respiratory Infections: Current Perspectives on Utility and Limitations.

Authors:  Priscilla Kim; Abhishek Deshpande; Michael B Rothberg
Journal:  Infect Drug Resist       Date:  2022-04-27       Impact factor: 4.177

4.  Modern diagnostics in emergency medicine.

Authors:  Jan Niederdöckl; Nina Buchtele; Michael Schwameis; Hans Domanovits
Journal:  Wien Klin Wochenschr       Date:  2021-03       Impact factor: 1.704

5.  CAPPRIC Study-Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings.

Authors:  Jesús Molina; Amelia González-Gamarra; Leovigildo Ginel; Mª Encarnación Peláez; Juan Luis Juez; Antonio Artuñedo; Gonzalo Aldana; Enriqueta Quesada; Joan Josep Cabré; Antonio Gómez; Manuel Linares; Maria Teresa Marín; Pilar Yolanda Sanchez; Leonor Núñez; Jaime Gonzálvez; Enrique Mascarós; Javier López; Agustina Cano; José Herrero; María Carmen Serra; Enrique Cimas; Marta Pedrol; Juan Vicente Alfaro; Federico Martinón-Torres; Isabel Cifuentes; Cristina Méndez; Daniel Ocaña
Journal:  Microorganisms       Date:  2021-02-28

6.  A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany.

Authors:  Christina Bahrs; Miriam Kesselmeier; Martin Kolditz; Santiago Ewig; Gernot Rohde; Grit Barten-Neiner; Jan Rupp; Martin Witzenrath; Tobias Welte; Mathias W Pletz
Journal:  Eur Respir J       Date:  2022-02-03       Impact factor: 16.671

7.  Diagnostic accuracy of urinary antigen tests for pneumococcal pneumonia among patients with acute respiratory failure suspected pneumonia: a systematic review and meta-analysis.

Authors:  Shunsuke Yasuo; Maki Murata; Natsuki Nakagawa; Takeshi Kawasaki; Takuo Yoshida; Koichi Ando; Satoshi Okamori; Yohei Okada
Journal:  BMJ Open       Date:  2022-08-11       Impact factor: 3.006

8.  Presentation and outcome of suspected sepsis in a high-HIV burden, high antiretroviral coverage setting.

Authors:  Wendy Chaka; Christopher Berger; Stella Huo; Valerie Robertson; Chipo Tachiona; Marcelyn Magwenzi; Trish Magombei; Chengetai Mpamhanga; David Katzenstein; John Metcalfe
Journal:  Int J Infect Dis       Date:  2020-04-11       Impact factor: 3.623

9.  Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis.

Authors:  Louise Lansbury; Benjamin Lim; Tricia M McKeever; Hannah Lawrence; Wei Shen Lim
Journal:  EClinicalMedicine       Date:  2022-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.